XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2023

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

We disaggregate our net sales by business and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.

Beginning in the first quarter of 2023, we consolidated Other MedSurg and Neurotechnology into Endoscopy as Other MedSurg and Neurotechnology (primarily Sustainability Solutions) has been fully integrated into our Endoscopy business. Endoscopy includes sales related to Other of $81 and $69 for the three months 2023 and 2022. We have reflected these changes in all historical periods presented.

Net Sales by Business
			Three Months
			2023			2022
MedSurg and Neurotechnology:
Instruments			$	575		$	528
Endoscopy			698			607
Medical			778			664
Neurovascular			284			301
Neuro Cranial			355			323
			$	2,690		$	2,423
Orthopaedics and Spine:
Knees			$	566		$	464
Hips			375			327
Trauma and Extremities			769			685
Spine			284			279
Other			94			97
			$	2,088		$	1,852
Total			$	4,778		$	4,275

Net Sales by Geography
			Three Months 2023									Three Months 2022
			United States			International						United States			International
MedSurg and Neurotechnology:
Instruments			$	450		$	125					$	414		$	114
Endoscopy			564			134						486			121
Medical			612			166						525			139
Neurovascular			118			166						110			191
Neuro Cranial			289			66						264			59
			$	2,033		$	657					$	1,799		$	624
Orthopaedics and Spine:
Knees			$	416		$	150					$	345		$	119
Hips			236			139						202			125
Trauma and Extremities			554			215						487			198
Spine			212			72						200			79
Other			61			33						72			25
			$	1,479		$	609					$	1,306		$	546
Total			$	3,512		$	1,266					$	3,105		$	1,170

Contract with Customer, Contract Asset, Contract Liability, and Receivable

Changes in contract liabilities during the year were as follows:

			March 2023
Beginning contract liabilities			$	741
Revenue recognized from beginning of year contract liabilities			(129)
Net advance consideration received during the period			145
Ending contract liabilities			$	757

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration